The funding round was jointly backed by NPIF and Finance Yorkshire with £500k each.
"Healthcare services worldwide rely on rapid and accurate laboratory testing. However, training staff is costly, and machine downtime is commonplace, often due to operator error or simple faults that could easily be fixed with the right support. We believe our platform will dramatically improve productivity by enhancing staff skills and keeping equipment up and running, while also reducing warranty costs for manufacturers."
The biotechnology firm raised fresh capital to accelerate growth in American and European markets and complete new laboratory facilities.
"Over the last year we’ve demonstrated the market for novel and improved in vitro testing methods and expanded our customer base as well as the Aelius team. Along with our move to our new premises, this latest funding will enable us to accelerate our growth in international markets, particularly in the US."
The funding round was led by Mercia Ventures and will support team expansion and platform development.
"Our mission is to simplify the complex world of energy and building management systems, empowering building operators to reduce carbon emissions and save money. Our focus on tangible results has led to a huge increase in demand from businesses to join the Grid Edge community. This funding will enable us to welcome more businesses on board, accelerating our growth and extending our reach and impact."
The funding round was backed by the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group.
"Our mission is to help companies avoid unnecessary animal testing and provide more accurate and relevant test results. This latest funding will enable us to continue building our range of tests and assays and use our model for different purposes, across different industries. We will also continue engaging with regulators to adapt industry standards tests to become animal free, and establish ImmuONE as a leading provider."
-1.png)
